# DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.

Study · id `cardio:ct-nct06657833` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06657833](<https://clinicaltrials.gov/study/NCT06657833>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06657833

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 128 participants.

## Technical summary

Registry record NCT06657833. Randomized; no masking; primary purpose treatment. Start 2024-12-17 (actual); primary completion 2027-10-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 128 participants (planned count; ClinicalTrials.gov record NCT06657833, source copy `cardio:ctgov-nct06657833-2026-09-30`, retrieved 2026-10-26)
- Started: 2024-12-17 (actual) (ClinicalTrials.gov record NCT06657833, source copy `cardio:ctgov-nct06657833-2026-09-30`, retrieved 2026-10-26)
- Primary completion: 2027-10-30 (anticipated) (ClinicalTrials.gov record NCT06657833, source copy `cardio:ctgov-nct06657833-2026-09-30`, retrieved 2026-10-26)
- Completion: 2027-10-30 (anticipated) (ClinicalTrials.gov record NCT06657833, source copy `cardio:ctgov-nct06657833-2026-09-30`, retrieved 2026-10-26)
- Countries: Netherlands; Spain (ClinicalTrials.gov record NCT06657833, source copy `cardio:ctgov-nct06657833-2026-09-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06657833-2026-09-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.
- Acronym: DEBSCAN-IVL
- Condition: Coronary Artery Disease
- Intervention (Device): Percutaneous coronary intervention of a calcified nodule with intravascular lithotripsy followed by drug eluting balloon
- Intervention (Device): Percutaneous coronary intervention of a calcified nodule with intravascular lithotripsy followed by drug eluting stent
- Lead sponsor: Fundación EPIC
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Fundación EPIC (`cardio:org-fundacion-epic`)

## Provenance

Content hash: 8dca378423c8c0cf03536bfb87eef34e755a5abec1827eb06c05e191038ee098
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
